Loteprednol Side Effects

Please note - some side effects for Loteprednol may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.

Side Effects of Loteprednol - for the Consumer

Loteprednol Drops

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome when using Loteprednol Drops:

Blurred vision; discharge; dry eyes; eye redness; eye/eyelid swelling; foreign body sensation; headache; increased tearing; itching; runny nose; sensitivity to light; sore throat; stinging when placed in the eye.

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); changes in vision; continued or worsening itching; delayed healing after surgery; eye pain; severe redness or swelling.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

Side Effects by Body System - for Healthcare Professionals

Applies to: ophthalmic ointment; ophthalmic suspension

Ocular

Ocular side effects have included abnormal vision/blurring, burning on instillation, chemosis, discharge, dry eyes, epiphora, foreign body sensation, itching, injection, and photophobia in 5% to 15% of patients. Conjunctivitis, corneal abnormalities, eyelid erythema, keratoconjunctivitis, ocular irritation,/pain/discomfort, papillae, and uveitis have been reported in <5% of patients. (Some of the adverse reactions reported were similar to the underlying ocular disease being treated.)

Corticosteroids have also been reported to cause elevated intraocular pressure, optic nerve damage, visual acuity and field defects, cataracts, secondary infections, acute anterior uveitis, perforation of the globe, keratitis, conjunctivitis, corneal ulcers, mydriasis, conjunctival hyperemia, loss of accommodation, and ptosis.

Randomized studies involving patients treated with loteprednol etabonate therapy for 28 days or longer revealed the incidence of significant elevation in intraocular pressure (>= 10 mmHg) was 2% (15/901) with loteprednol etabonate, 7% (11/164) with 1% prednisolone acetate and 0.5% (3/583) with placebo.

Respiratory

Respiratory system side effects have included rhinitis and pharyngitis (<15%).

Nervous system

Nervous system side effects have included headache (<15%).

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.